首页> 外国专利> METHOD FOR PREDICTION OF CLINICAL OUTCOME OF EXTRACORPOREAL FERTILISATION AND EMBRYO TRANSFER

METHOD FOR PREDICTION OF CLINICAL OUTCOME OF EXTRACORPOREAL FERTILISATION AND EMBRYO TRANSFER

机译:预测球体外受精和胚胎移植临床结果的方法

摘要

FIELD: medicine.;SUBSTANCE: invention may be used for prediction of the clinical outcomes of the extracorporeal fertilisation (EF) program and embryo transfer (ET) in females suffering sterility of various geneses. Substance of the invention consists in the fact that before the ovarian stimulation, peripheral venous blood leukocytes of a sterile female are examined for class II HLA gene polymorphism; if detecting the carrier state of DQA1*0101-DQB1*0501 or DQA1*0102-DQB1*0502 haplotypes, an unfavourable outcome of the EF and ET programs (pregnancy failure) is predicted, while no DQA1*0101-DQB1*0501 and DQA1*0102-DQB1*0502 haplotypes ensure predicting the favourable outcome of the EF and ET programs (pregnancy).;EFFECT: simplified and enhanced prediction of the clinical outcomes of the EF and ET programs in females suffering sterility of various geneses that enables considerably higher effectiveness of the assisted reproductive treatment ensured by more accurate selection of the patients at the stage of planning for pregnancy.;1 tbl, 3 ex
机译:领域:药物;发明:本发明可用于预测患有各种基因不育的女性的体外受精(EF)程序和胚胎移植(ET)的临床结果。本发明的实质在于,在卵巢刺激之前,检查不育雌性的外周静脉血白细胞的II类HLA基因多态性。如果检测到DQA1 * 0101-DQB1 * 0501或DQA1 * 0102-DQB1 * 0502单倍型的载体状态,则预测EF和ET程序的结果不佳(怀孕失败),而没有DQA1 * 0101-DQB1 * 0501和DQA1 * 0102-DQB1 * 0502单倍型可确保预测EF和ET计划的良好结局(怀孕)。效果:简化和增强对各种基因不育女性的EF和ET计划的临床结局的预测,可大大提高在计划怀孕的阶段更准确地选择患者,可以确保辅助生殖治疗的有效性。1tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号